FDA approves Sun ulcer drug
MUMBAI, India — The Food and Drug Administration has approved a drug made by Sun Pharmaceutical Industries for ulcers, Sun said.
Sun announced the approval of lansoprazole delayed-release capsules in the 15-mg and 30-mg strengths.
The drug is a generic version of Takeda's Prevacid delayed-release capsules, which are used for treatment lasting up to four weeks for healing and symptom relief of active duodenal ulcers.
Various versions of the drug have annual sales of about $430 million per year, according to Sun.